Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 26% ± 12% |
Insufficient scRNA-seq data for expression of SARDH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 7743.19 | 226 / 226 | 96% | 49.06 | 389 / 406 |
kidney | 100% | 830.40 | 89 / 89 | 84% | 7.16 | 753 / 901 |
prostate | 98% | 352.04 | 241 / 245 | 73% | 8.13 | 366 / 502 |
pancreas | 100% | 2344.77 | 328 / 328 | 71% | 3.32 | 126 / 178 |
thymus | 99% | 254.15 | 644 / 653 | 70% | 3.43 | 425 / 605 |
adrenal gland | 98% | 278.39 | 252 / 258 | 67% | 13.04 | 153 / 230 |
lung | 99% | 425.38 | 574 / 578 | 52% | 2.36 | 606 / 1155 |
ovary | 100% | 416.08 | 180 / 180 | 50% | 2.27 | 214 / 430 |
brain | 97% | 324.01 | 2572 / 2642 | 44% | 2.13 | 311 / 705 |
breast | 74% | 127.73 | 338 / 459 | 67% | 4.90 | 750 / 1118 |
uterus | 97% | 283.17 | 165 / 170 | 35% | 2.04 | 160 / 459 |
stomach | 96% | 310.14 | 345 / 359 | 26% | 1.03 | 73 / 286 |
intestine | 92% | 165.05 | 886 / 966 | 19% | 0.82 | 98 / 527 |
bladder | 90% | 170.95 | 19 / 21 | 19% | 0.88 | 96 / 504 |
skin | 47% | 87.55 | 843 / 1809 | 59% | 4.95 | 279 / 472 |
eye | 0% | 0 | 0 / 0 | 100% | 18.64 | 80 / 80 |
spleen | 100% | 196.20 | 240 / 241 | 0% | 0 | 0 / 0 |
esophagus | 57% | 75.63 | 830 / 1445 | 24% | 1.15 | 44 / 183 |
adipose | 77% | 128.67 | 922 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 4.37 | 22 / 29 |
heart | 68% | 147.66 | 587 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 50% | 59.24 | 672 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 50% | 58.51 | 460 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 44% | 1.64 | 20 / 45 |
muscle | 34% | 35.87 | 276 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901053 | Biological process | sarcosine catabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0008480 | Molecular function | sarcosine dehydrogenase activity |
Gene name | SARDH |
Protein name | Sarcosine dehydrogenase SARDH protein Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) Uncharacterized protein SARDH |
Synonyms | hCG_1640945 DMGDHL1 |
Description | FUNCTION: Catalyzes the last step of the oxidative degradation of choline to glycine. Converts sarcosine into glycine. . |
Accessions | Q9UL12 Q05BT1 Q5SYV2 ENST00000298628.6 ENST00000439388.6 [Q9UL12-1] ENST00000371872.8 [Q9UL12-1] ENST00000371867.5 Q9UL10 Q9UL11 Q5SYV1 Q5SYU9 ENST00000427237.6 ENST00000371868.5 |